NOVUMWORLD | 🧠 AI/SAAS
  • EN
  • ES
SECCIONES
  • AI & SaaS
  • Crypto
  • Biohacking
  • Creators
  • Viral
  • Tools
  • Funds
  • About Us
  • Privacy Policy
  • Terms of Service
  • Contact

© 2026 NOVUMWORLD. INDEPENDENT UNFILTERED JOURNALISM.

AI & SaaS

Technical analysis of Artificial Intelligence and B2B SaaS tools.

Kleiner Perkins' $3.5B AI Bet: Hallucinations Could Cost Them Everything.
ia

Kleiner Perkins' $3.5B AI Bet: Hallucinations Could Cost Them Everything.

Kleiner Perkins stakes billions on AI, but risky 'hallucinations' threaten to derail their investment. Can they overcome AI's flaws for massive returns?.
Read More
RTX 5090 Required? DLSS 5's Dirty Little Secret NVIDIA Doesn't Want You To Know
ia

RTX 5090 Required? DLSS 5's Dirty Little Secret NVIDIA Doesn't Want You To Know

Is NVIDIA's RTX 5090 secretly required for DLSS 5 to shine? We expose the performance cost and upscaling's hidden reliance on next-gen hardware.
Read More
95% Of ATMs Run On COBOL: The Tech Time Bomb In Your Wallet
ia

95% Of ATMs Run On COBOL: The Tech Time Bomb In Your Wallet

Your money's digital, but surprisingly archaic code powers ATMs. 95% run on COBOL, a 60-year-old language! Is this dependence a ticking tech time bomb.
Read More
90% Of AI Startups Fail: Is Your Series A Investment a Unicorn Corpse?
ia

90% Of AI Startups Fail: Is Your Series A Investment a Unicorn Corpse?

Investing in AI startups? 90% fail post-Series A. Discover hidden warning signs that separate future unicorns from potential zombie companies before you.
Read More
90% Of AI Projects Will Fail: VC's $258 Billion Disaster Waiting To Happen
ia

90% Of AI Projects Will Fail: VC's $258 Billion Disaster Waiting To Happen

VCs poured $258B into AI, yet 90% of projects face failure. Is the AI hype a bubble about to burst? Uncover the shocking truth and avoid becoming a.
Read More
AI Pharma's Dirty Secret: 90% Trial Failure Rate Still Haunts $25B Boom
ia

AI Pharma's Dirty Secret: 90% Trial Failure Rate Still Haunts $25B Boom

AI Pharma's $25B boom hides a harsh truth: despite the hype, a shocking 90% of AI-driven drug trials still fail. Explore the reasons behind this costly.
Read More
  • ««
  • «
  • 5
  • 6
  • 7
  • 8
  • 9
  • »
  • »»
© NovumWorld 2026
About Us Contact Privacy Policy Terms of Service

© 2026 NOVUMWORLD. INDEPENDENT UNFILTERED JOURNALISM.

We use our own and third-party cookies to personalize content, analyze traffic, and display advertising through our advertising partners. By clicking 'Accept', you consent to their use. See our Privacy Policy and Cookie Policy.